Immune Modulation in Cancer with Antibodies
Author:
Affiliation:
1. Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, New York, New York 10065;, , ,
2. Department of Immunology, M.D. Anderson Cancer Center, Houston, Texas 77030;
Abstract
Publisher
Annual Reviews
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://www.annualreviews.org/doi/pdf/10.1146/annurev-med-092012-112807
Cited by 438 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic significance of circulating exosomal PD-L1 in various malignant tumors: A systematic review and meta-analysis;2024-01-22
2. Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy;Cell Death Discovery;2024-01-12
3. Balancing the Nanoscale Organization in Multivalent Materials for Functional Inhibition of the Programmed Death-1 Immune Checkpoint;ACS Nano;2023-12-21
4. Early recovery of leukocyte subsets is associated with progression-free survival in patients with inoperable stage III NSCLC after multimodal treatment: a prospective explorative study;2023-11-21
5. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy;Expert Opinion on Drug Delivery;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3